Custodiol versus blood cardioplegia in complex cardiac operations: An Australian experience

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 3, 2013, Pages 526-531

  Viana, Fabiano F ^a   Shi, William Y ^b   Hayward, Philip A ^b   Larobina, Marco E ^b   Liskaser, Frank ^b   Matalanis, George ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

Bretschneider; Cardiac surgery; Cardioplegia; Histidine tryptophan ketoglutarate solution; Myocardial protection

Indexed keywords

HTK SOLUTION;

AGED; ARTICLE; AUSTRALIA; CARDIOPLEGIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DATA BASE; FEMALE; HEART INFARCTION; HEART SURGERY; HOSPITAL READMISSION; HUMAN; INTRAAORTIC BALLOON PUMP; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL;

AGED; AUSTRALIA; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; GLUCOSE; HEART ARREST, INDUCED; HUMANS; MALE; MANNITOL; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84873651902     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs319     Document Type: Article

References (17)

1. Sakata J, Morishita K, Ito T, Koshino T, Kazui T, Abe T. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement. J Card Surg 1998;13:43-7.
2. Schaper J, Scheld H, Schmidt U, Hehrlein F. Ultrastructural study comparing the efficacy of five different methods of intraoperative myocardial protection in the human heart. J Thorac Cardiovasc Surg 1986;92:47-55.
3. Murashita T, Yasuda K. Comparison of the protective properties of St Thomas', tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart. Nihon Kyobu Geka Gakkai Zasshi 1996;44:2019-26.
4. Camilleri L, Moins N, Mouchonière M, Renoux M, Bailly P, Veyre A et al. Cultured neonatal rat cardiomyocytes and 99mtc-sestamibi to assess the direct effects of cardioplegia. Cardiovasc Surg 1998;6:614-21.
5. Podesser B, Wollenek G, Windischbauer A, Zegner M, Hausleithner V, Seitelberger R et al. Myocardial protection with Bretschneider cardioplegic solution-an evaluation of full oxygenation. Eur Surg Res 1994;26:133-40.
6. Andrianopoulos N, Dinh D, Duffy S, Clark D, Brennan A, Chan W et al. Quality control activities associated with registries in interventional cardiology and surgery. Heart Lung Circ 2011;20:180-6.
7. Austin P. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007;134:1128-35.
8. Kresh J, Nastala C, Bianchi P, Goldman S, Brockman S. The relative buffering power of cardioplegic solutions. J Thorac Cardiovasc Surg 1987;93: 309-11.
9. del Nido P, Wilson G, Mickle D, Bush B, Rebeyka I, Klement P et al. The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment. J Thorac Cardiovasc Surg 1985;89:689-99.
10. Hachida M, Nonoyama M, Bonkohara Y, Hanayama N, Saitou S, Maeda T et al. Clinical assessment of prolonged myocardial preservation for patients with a severely dilated heart. Ann Thorac Surg 1997;64:59-63.
11. Takeuchi K, Akimoto H, Maida K, Munakata M, Fukui K, Daitoku K et al. Myocardial protection of the pressure overload hypertrophied heart in human cardiac surgery by acceleration of anaerobic glycolysis. J Cardiovasc Surg (Torino) 2002;43:37-41.
12. Saitoh Y. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function. Ann Thorac Surg 2000;69:107-12.
13. Yang Q, Zhang R, Yim A, He G. Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyperpolarization factormediated function during heart preservation: comparison with University of Wisconsin solution. J Heart Lung Transpl 2004;26:352-9.
14. Fannelop T, Dahle G, Salminen P, Moen C, Matre K, Mongstad A et al. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig. Ann Thorac Surg 2009;87:1205-13.
15. Braathen B, Jeppsson A, Scherstén H, Hagen O, Vengen Ø, Rexius H et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg 2011;141:995-1001.
16. von Oppell U, Pfeiffer S, Preiss P, Dunne T, Zilla P, Reichart B. Endothelial cell toxicity of solid-organ preservation solutions. Ann Thorac Surg 1990; 50:902-10.
17. Liu J. The myocardial protection of HTK cardioplegic solution on the longterm ischemic period in pediatric heart surgery. ASAIO J. 2008;54:470-3.